Zentalis Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €57.72M +∞% -€141.97M -43.2% -246.0% -2.5 pp -€146.08M -17.7% -253.1% -2.5 pp
    €0.00 +NaN% -€250.14M +23.4% N/A -€177.42M +28.6% N/A
    €0.00 +NaN% -€202.73M +44.2% N/A -€138.00M +8.9% N/A
    €0.00 +NaN% -€140.62M +38.6% N/A -€126.69M +71.9% N/A
    €0.00 +NaN% -€101.49M +155.6% N/A -€73.68M +121.9% N/A
    €0.00 -100.0% -€39.70M +120.1% N/A -€33.21M +61.5% N/A
    €11.99K -€18.04M -150,478.6% -€20.57M -171,600.0%

    Notifications